Pulse ·

Australia records 538 diphtheria cases — the largest outbreak since 1991

Verdict Yes — worth knowing about

Australia's 2026 diphtheria outbreak has reached 538 cases — the largest since records began in 1991 and 17 times the previous peak. Cases concentrate in remote NT and WA, mostly skin lesions, predominantly affecting Aboriginal and Torres Strait Islander communities.

Many cases occurred in people with completed childhood vaccination, confirming immunity wanes. A $13 million federal response is under way; experts say housing and sanitation improvements are equally essential for elimination.

For GPs: confirm adult dTpa booster history and consider diphtheria in non-healing skin ulcers with a grey membrane after remote-area exposure.

What just happened

Australia is managing its largest diphtheria outbreak in modern records. By 25 August 2026, the case count had reached 538 — a number that sounds abstract until you compare it to the previous peak: 31 cases in 2022. That is not a gradual rise. It is a 17-fold increase over what had been the record high.

The cases are concentrated in remote Northern Territory and Western Australia, with additional cases in South Australia and Queensland. Most are cutaneous diphtheria — skin infections — not the classical presentation involving the throat and the grey pseudomembrane that older medical training emphasised. The disease is predominantly affecting Aboriginal and Torres Strait Islander people in remote and outer regional areas, in communities where housing density, limited water access, and skin injury from insect bites create the structural conditions for bacterial spread.

Public health experts have noted that testing rates across affected areas have declined, meaning the recorded 538 is likely an undercount. The actual burden of disease in affected communities is probably higher.

Both-and

The vaccine story is more complicated than it looks

The instinct when an infectious disease outbreak emerges is to reach for vaccination status as the explanation. In this outbreak, vaccination status does not carry that weight in the way the framing implies.

A high proportion of the 2026 cases have occurred in people who received at least three valid vaccine doses — that is, people who completed their childhood immunisation course. This is not a story of an unvaccinated population. It is a story of immunity waning over time and adult booster schedules not keeping pace.

Diphtheria immunity from childhood vaccination is not permanent. The standard recommendation is a single dTpa booster for any adult who has never had one as an adult, and additional boosters in pregnancy. In practice, adult booster documentation is inconsistent across general practice records, and many people who completed childhood vaccination in the 1980s and 1990s have no record of any subsequent booster. This matters for how the consultation goes.

Vaccination remains the right tool. The point is not that vaccines have failed — it is that childhood-only coverage is not the same as maintained adult immunity, and the adult booster program has not reached the people most affected by this outbreak.

What vaccination cannot do alone

Diphtheria has been effectively eliminated from high-income urban Australia. Its persistence in remote communities is not primarily a vaccine-coverage story. It is a story about housing and sanitation.

Experts emphasise that meaningful improvements to housing and sanitation are equally essential alongside vaccination surge capacity for lasting elimination. Cutaneous diphtheria spreads through skin-to-skin contact and contact with contaminated surfaces. In households with many people sharing limited space, with inadequate facilities for wound care and hygiene, bacterial spread is structurally enabled regardless of vaccination rates.

The federal government’s $13 million response covers vaccination surge capacity, antitoxin treatment, and community health liaisons. That is appropriate for the acute outbreak. The elimination question — whether Australia can achieve what was achieved historically — depends on structural conditions that a vaccination campaign alone cannot change.

This is the part of the story that tends to drop out of press coverage, and it matters: the outbreak reflects a failure of housing policy, not just a lapse in immunisation program delivery. Both are true simultaneously.

The skin presentation most GPs won’t recognise on sight

Classical diphtheria teaching focuses on the throat: the grey pseudomembrane, the bull-neck lymphadenopathy, the risk of airway obstruction. Most GPs practising today have not seen a case in their career. The 2026 outbreak is primarily cutaneous, and the clinical presentation is different.

Cutaneous diphtheria typically presents as a chronic non-healing ulcer with a grey or dirty-looking membrane — often on the lower legs or feet in people with existing skin breakdown. The patient is not acutely unwell in the dramatic way that laryngeal diphtheria presents. It can be mistaken for a tropical ulcer, an infected insect bite, or a chronic wound with secondary bacterial colonisation.

The clinical clue is context: a skin ulcer that will not heal in a person who has lived in or recently returned from affected communities in the NT or WA, or who has had close contact with someone from those areas. Confirmation requires swab for culture and sensitivity. Diphtheria antitoxin and antibiotics (penicillin or erythromycin) are the treatment, and antitoxin is sourced through public health channels — which means early notification to the public health unit is the first practical step.

My two cents

This outbreak will be framed in some commentary as a vaccination failure. The data makes that framing incomplete. The failure is more specifically structural: we have a vaccine that works but wanes, adult booster programs that are unevenly implemented, and housing conditions in remote communities that create the transmission conditions that no immunisation campaign can fully overcome on its own.

For the consultation: checking adult dTpa booster history takes 30 seconds and is particularly worth doing with patients who grew up in the 1970s, 1980s, or 1990s and have no documented adult booster — a larger proportion of the general practice population than is commonly assumed. For patients with remote-area connections or recent travel to affected regions, that check becomes more pressing.

The grey membranous skin ulcer that will not heal is the clinical clue. If you are seeing it, notify the public health unit and do not wait for culture confirmation before commencing antibiotics.

Verdict: yes — the scale of this outbreak is clinically significant, the vaccine-and-immunity picture is more nuanced than early coverage suggests, and there are practical steps available in general practice now.


Sources cited

  1. As cases surpass 500, can Australia eliminate diphtheria again? ABC Health, 25 August 2026. https://www.abc.net.au/news/2026-08-25/as-cases-surpass-500-can-australia-eliminate-diphtheria-again/107070542

Frequently asked questions

  • Does completing the childhood diphtheria vaccine course mean lasting protection?

    Childhood vaccination provides strong early protection but immunity wanes over time — which is why the 2026 outbreak has affected a significant proportion of vaccinated people. Australian immunisation guidelines recommend a single adult dTpa (diphtheria-tetanus-pertussis) booster for any adult who has never had one as an adult, and additional boosters in certain circumstances such as pregnancy or pre-travel to affected areas. If a patient has not had a booster since their early teens, their diphtheria protection is lower than they may assume.

  • Why are most 2026 cases involving skin lesions rather than throat disease?

    Cutaneous diphtheria tends to spread in settings with crowded housing, skin breakdown from insect bites or minor wounds, and limited access to clean water and wound care — the structural conditions present in many of the remote communities where cases are concentrated. Cutaneous disease is generally less immediately life-threatening than laryngeal diphtheria, but the bacteria can still produce toxin and the lesions are infectious. The grey membranous skin ulcer in a person with remote-area exposure is the clinical clue to consider.